share_log

ADC Therapeutics Expects That Product Revenues, Net, Will Be About $19.8M For Three Months Ended Dec. 31, 2022; Expects Cash And Cash Equivalents Will Be About $326.4M As Of Dec. 31, 2022

ADC Therapeutics Expects That Product Revenues, Net, Will Be About $19.8M For Three Months Ended Dec. 31, 2022; Expects Cash And Cash Equivalents Will Be About $326.4M As Of Dec. 31, 2022

ADC Therapeutics预计,截至2022年12月31日的三个月中,产品净收入将约为1,980万美元;预计截至2022年12月31日,现金和现金等价物将约为3.264亿美元
Benzinga Real-time News ·  2023/02/02 06:34

ADC Therapeutics Expects That Product Revenues, Net, Will Be About $19.8M For Three Months Ended Dec. 31, 2022; Expects Cash And Cash Equivalents Will Be About $326.4M As Of Dec. 31, 2022

ADC Therapeutics预计,截至2022年12月31日的三个月中,产品净收入将约为1,980万美元;预计截至2022年12月31日,现金和现金等价物将约为3.264亿美元

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发